Skip to ContentSkip to Navigation
How to find us prof. dr. H.W. (Hans) Nijman

Publications

Association of homozygous variants of STING1 with outcome in human cervical cancer

Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer

Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring

Frozen section diagnosis of borderline ovarian tumors with suspicious features of invasive cancer is a devil's dilemma for the surgeon: A systematic review and meta-analysis

In Vitro Systematic Drug Testing Reveals Carboplatin, Paclitaxel, and Alpelisib as a Potential Novel Combination Treatment for Adult Granulosa Cell Tumors

Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial

No improvement in survival of older women with cervical cancer-A nationwide study

Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making

Read more

Press/media

Immunicum : Interim report Jan-June 2021 | MarketScreener

Immunicum AB (publ) Interim Report April - June 2021

Immunicum Immunicum AB (publ) Interim Report April - June 2021 (GlobeNewswire)

A Fast Track for Cancer Vaccines

Interview bij ZonMW

Immunoncologie artikel therapeutisch HPV vaccin voor cervixcarcinoom

Kankervaccin klaar voor tests op patiënten

Read more